|
Click on one of the congress days:
|
|
Friday, 20 April 2007
Saturday, 21 April 2007
Monday, 23 April 2007
Tuesday, 24 April 2007
Wednesday, 25 April 2007
|
|
|
|
| |
|
| Search Abstract |
| |
|
|
| |
| |
|
| Friday, 20 April 2007 |
| |
| 11:00-12:30 | |
| Oral session I -TD/MC |
|
|
| |
| 11:00-12:30 | |
| Oral session I - DM/DT/TOX-SAF |
|
|
| |
| 11:00-12:30 | |
| Oral session I -DD Biology |
|
|
| |
| 11:00-12:30 | |
| Oral session I -PA/QA/RA |
|
|
| |
| 11:00-12:30 | |
| Oral session I -CP/PK-PD/PE |
|
|
| |
| 11:00-12:30 | |
| Oral session I - DD Technology |
|
|
| |
| 14:00-15:30 | |
| Oral session II -TD/MC |
|
|
| |
| 14:00-15:30 | |
| Oral session II - DM/DT/TOX-SAF |
|
|
| |
| 14:00-15:30 | |
| Oral session II -DDBiology |
|
|
| |
| 14:00-15:30 | |
| Oral session II - DD Technology |
|
|
| |
| 14:00-15:30 | |
| Oral session II -CP/PK-PD/PE |
|
|
| |
| 14:00-15:30 | |
| Oral session II - DD Technology |
|
|
| |
| 16:00-17:00 | |
| Oral session III - TD/MC |
|
|
| |
| 16:00-17:00 | |
| Oral session III - CP/PK-PD/PE |
|
|
| |
| 16:00-17:00 | |
| Oral session III - DD Biology |
|
|
| |
| 16:00-17:00 | |
| Oral session III - PA/QA/RA |
|
|
| |
| 16:00-17:00 | |
| Oral session III CP/PK-PD/PE |
|
|
| |
| 16:00-17:00 | |
| Oral session III - DD Technology |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Medicinal Chemistry and Natural Products |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Drug Metabolism and Transport |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Pharmacokinetics and Pharmacodynamics |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Toxicology and Safety Sciences |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Pharmacokinetics and Pharmacogenetics |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Formulation, Delivery, Biopharmaceutics and Pharmaceutical Technology |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Pharmaceutical Analysis, Bioanalysis, Quality Assurance/Control and Regulatory Affairs |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Clinical Pharmacology and Biomarkers |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Pharmacoepidemiology and Pharmacovigilance |
|
|
| |
| 17:00-18:30 | |
| Poster walk Friday Target Discovery and Molecular Pharmacology |
|
|
| |
| Saturday, 21 April 2007 |
| |
| 11:15-12:45 | |
| Oral session IV -TD/MC |
|
|
| |
| 11:15-12:45 | |
| Oral session IV - DM/DT/TOX-SAF |
|
|
| |
| 11:15-12:45 | |
| Oral session IV -DD Biology |
|
|
| |
| 11:15-12:45 | |
| Oral session IV -DD Biology |
|
|
| |
| 11:15-12:45 | |
| Oral session IV CP/PK-PD/PE |
|
|
| |
| 11:15-12:45 | |
| Oral session IV - DD Technology |
|
|
| |
| Monday, 23 April 2007 |
| |
| 08:30-11:15 | |
| The era of personalised health care: Impact on drug discovery and development? |
|
|
| |
| 08:30-11:15 | |
| Is gene/protein delivery delivering? |
|
|
| |
| 08:30-11:15 | |
| Can ADME and PK be predicted from in silico/in vitro data? |
|
|
| |
| 08:30-11:15 | |
| Metabolomics: What are the opportunities for biomarker discovery? |
|
|
| |
| 08:30-11:15 | |
| What benefits does Process Analytical Technology (PAT) bring to the design and assurance of product quality? |
|
|
| |
| 08:30-11:15 | |
| What have we learnt from recent safety cases for new drug development? |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Medicinal Chemistry and Natural Products |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Drug Metabolism and Transport |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Pharmacokinetics and Pharmacodynamics |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Pharmacokinetics and Pharmacogenetics |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Formulation, Delivery, Biopharmaceutics and Pharmaceutical Technology |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Pharmaceutical Analysis, Bioanalysis, Quality Assurance/Control and Regulatory Affairs |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Clinical Pharmacology and Biomarkers |
|
|
| |
| 08:30-16:45 | |
| Poster session Monday Pharmacoepidemiology and Pharmacovigilance |
|
|
| |
| 14:15-16:30 | |
| Pharmacogenetics at the bedside? |
|
|
| |
| 14:15-16:30 | |
| What will be the impact of cell-based therapy? |
|
|
| |
| 14:15-16:30 | |
| Simulation and modelling in drug development improves decisions, saving time and money? |
|
|
| |
| 14:15-16:30 | |
| Dirty vs selective drugs in the CNS? |
|
|
| |
| 14:15-16:30 | |
| How will developments in chemical methods sustain pharmaceutical industrial development? |
|
|
| |
| 14:15-16:30 | |
| How effective is the globalisation/ harmonisation ofpharmacovigilance? |
|
|
| |
| Tuesday, 24 April 2007 |
| |
| 08:30-11:15 | |
| Druggability: A concept that will fill the pipeline? |
|
|
| |
| 08:30-11:15 | |
| Drug targeting: How successful are we? |
|
|
| |
| 08:30-11:15 | |
| What is the state-of-the-science in receptor site modelling? |
|
|
| |
| 08:30-11:15 | |
| What’s new in methods of measuring human drug response? |
|
|
| |
| 08:30-11:15 | |
| In silico product development from molecule to man: Dream or reality? |
|
|
| |
| 08:30-11:15 | |
| Nutraceuticals: Are new methods of evaluating risk/benefit required? |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Target Discovery and Molecular Pharmacology |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Medicinal Chemistry and Natural Products |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Drug Metabolism and Transport |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Pharmacokinetics and Pharmacodynamics |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Formulation, Delivery, Biopharmaceutics and Pharmaceutical Technology |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Pharmaceutical Analysis, Bioanalysis, Quality Assurance/Control and Regulatory Affairs |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Clinical Pharmacology and Biomarkers |
|
|
| |
| 08:30-16:45 | |
| Poster session Tuesday Pharmacoepidemiology and Pharmacovigilance |
|
|
| |
| 14:15-16:30 | |
| Drug-drug interactions: Avoid or understand? |
|
|
| |
| 14:15-16:30 | |
| What is the future of smart, feed-back, on-demand drug delivery systems? |
|
|
| |
| 14:15-16:30 | |
| How are disease and PK-PD connected? |
|
|
| |
| 14:15-16:30 | |
| Have omics technologies improved the chance for successful drug development? |
|
|
| |
| 14:15-16:30 | |
| Are pharmaceutical manufacturing technologies in stagnation? |
|
|
| |
| 14:15-16:30 | |
| Are we using the right outcome measures to ascertain patient benefit from drug therapy? |
|
|
| |
| Wednesday, 25 April 2007 |
| |
| 08:30-16:45 | |
| Poster session Wednesday Formulation, Delivery, Biopharmaceutics and Pharmaceutical Technology |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Pharmaceutical Analysis, Bioanalysis, Quality Assurance/Control and Regulatory Affairs |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Clinical Pharmacology and Biomarkers |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Pharmacoepidemiology and Pharmacovigilance |
|
|
| |
| 08:30-11:15 | |
| How to manage drug therapy at the extremes of age? |
|
|
| |
| 08:30-11:15 | |
| How can nanotechnology and materials science solve drug delivery problems? |
|
|
| |
| 08:30-11:15 | |
| How important is genetic and physiological variability in drug transporters? |
|
|
| |
| 08:30-11:15 | |
| Systems biology: A driver of drug discovery and development? |
|
|
| |
| 08:30-11:15 | |
| How to engineer desired particle properties for drug delivery? |
|
|
| |
| 08:30-11:15 | |
| Off-label use of medicines: Abuse or a vehicle for innovation? |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Medicinal Chemistry and Natural Products |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Drug Metabolism and Transport |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Pharmacokinetics and Pharmacodynamics |
|
|
| |
| 08:30-16:45 | |
| Poster session Wednesday Toxicology and Safety Sciences |
|
|
| |
| 14:15-16:30 | |
| Is the patient taking the tablets? |
|
|
| |
| 14:15-16:30 | |
| Developing biotech products: What are the challenges and solutions? |
|
|
| |
| 14:15-16:30 | |
| Control of intracellular pharmacokinetics: Advantages for drug therapy? |
|
|
| |
| 14:15-16:30 | |
| Molecular targeting in cancer chemotherapy? |
|
|
| |
| 14:15-16:30 | |
| Miniaturisation in analytical methods: Is small always beautiful? |
|
|
| |
| 14:15-16:30 | |
| Counterfeiting of medicines: Detection and prevention? |
|
|
